The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Penetration enhancers
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dermatological formulations: Percutaneous absorption
(1984) · General Pharmacology: The Vascular System · doi:10.1016/0306-3623(84)90021-1 · Cited by 589
Terpenes and the Lipid–Protein–Partitioning Theory of Skin Penetration Enhancement
Williams, A. C., & Barry, B. W. (1991) · Pharmaceutical Research · doi:10.1023/a:1015813803205 · Cited by 550
Self-citationDermal Absorption and Toxicity Assessment
(2007) · CRC Press eBooks · doi:10.3109/9780849375927 · Cited by 340
Evidence that Oleic Acid Exists in a Separate Phase Within Stratum Corneum Lipids
Ongpipattanakul, B., Burnette, R. R., Potts, R. O., & Francoeur, M. L. (1991) · Pharmaceutical Research · doi:10.1023/a:1015845632280 · Cited by 323
Aungst, B. J., J. Rogers, N., & Shefter, E. (1986) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(86)90057-8 · Cited by 306
Lipid-Protein-Partitioning theory of skin penetration enhancement
Barry, B. W. (1991) · Journal of Controlled Release · doi:10.1016/0168-3659(91)90115-t · Cited by 301
Self-citationTransdermal drug delivery of imipramine hydrochloride. I. Effect of terpenes
Jain, A. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00524-7 · Cited by 224
Cornwell, P. A., Barry, B. W., Bouwstra, J. A., & Gooris, G. S. (1996) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(95)04108-7 · Cited by 224
Self-citationCornwell, P. A., & Barry, B. W. (1994) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1994.tb03791.x · Cited by 196
Self-citationAnigbogu, A. N. C., Williams, A. C., Barry, B. W., & Edwards, H. G. M. (1995) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(95)00141-5 · Cited by 188
Self-citationMegrab, N. A., Williams, A. C., & Barry, B. W. (1995) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(94)00321-u · Cited by 162
Self-citationStructure/Effect Studies of Fatty Acid Isomers as Skin Penetration Enhancers and Skin Irritants
Aungst, B. J. (1989) · Pharmaceutical Research · doi:10.1023/a:1015921702258 · Cited by 158
Williams, A. C., & Barry, B. W. (1991) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(91)90232-d · Cited by 150
Self-citationStructure of Fully Hydrated Human Stratum Corneum: A Freeze-Fracture Electron Microscopy Study
van Hal, D. A., Jeremiasse, E., Junginger, H. E., Spies, F., & Bouwstra, J. A. (1996) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12328031 · Cited by 131
Bond, J. R., & Barry, B. W. (1988) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12460958 · Cited by 117
Self-citationSouthwell, D., & Barry, B. W. (1983) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12535090 · Cited by 113
Self-citationAndega, S., Kanikkannan, N., & Singh, M. S. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00439-4 · Cited by 106
Lipid-protein-partitioning (LPP) theory of skin enhancer activity: finite dose technique
Goodman, M., & Barry, B. W. (1989) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(89)90260-3 · Cited by 100
Self-citationShed Snake Skin and Hairless Mouse Skin as Model Membranes for Human Skin During Permeation Studies
Rigg, P. C., & Barry, B. W. (1990) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12874561 · Cited by 91
Self-citationPilgram, G. S. K., van der Meulen, J., Gooris, G. S., Koerten, H. K., & Bouwstra, J. A. (2001) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(01)00271-1 · Cited by 84
Santoyo, S. (2000) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(00)00097-7 · Cited by 78
Hoogstraate, J. A., Verhoef, J., Brussee, J., IJzerman, A. P., Spies, F., & Boddé, H. E. (1991) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(91)90341-k · Cited by 78
Monti, D., Chetoni, P., Burgalassi, S., Najarro, M., Saettone, M. F., & Boldrini, E. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00032-7 · Cited by 77
Efficacy and irritancy of enhancers on the in-vitro and in-vivo percutaneous absorption of curcumin
Fang, J., Hung, C., Chiu, H.-C., Wang, J., & Chan, T. (2003) · Journal of Pharmacy and Pharmacology · doi:10.1211/002235703765344496 · Cited by 76
Tanojo, H., Geest, A. B.-V., Bouwstra, J. A., Junginger, H. E., & Boddé, H. E. (1997) · Thermochimica Acta · doi:10.1016/s0040-6031(97)00063-4 · Cited by 73
Optimization of Bioavailability of Topical Steroids: Penetration Enhancers Under Occlusion
Barry, B. W., Southwell, D., & Woodford, R. (1984) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12259101 · Cited by 69
Self-citationTupker, R. A., Pinnagoda, J., & Nater, J. P. (1990) · Acta Dermato Venereologica · doi:10.2340/000155557015 · Cited by 65
Toxic hygroscopic contact reaction to N‐methyl‐2‐pyrrolidone
Jungbauer, F., Coenraads, P. J., & Kardaun, S. H. (2001) · Contact Dermatitis · doi:10.1034/j.1600-0536.2001.450514.x · Cited by 53
The Potential of Metabolic Interventions to Enhance Transdermal Drug Delivery
Elias, P. M., Holleran, W. M., Feingold, K. R., Tsai, J., & Menon, G. K. (2002) · Journal of Investigative Dermatology Symposium Proceedings · doi:10.1046/j.1523-1747.2002.19632.x · Cited by 51
α-Bisabolol, a possible safe penetration enhancer for dermal and transdermal therapeutics
Kadir, R., & Barry, B. W. (1991) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(91)90167-m · Cited by 46
Self-citationEffect of Fatty Acid Diesters on Permeation of Anti-Inflammatory Drugs Through Rat Skin
Takahashi, K., Sakano, H., Numata, N., Kuroda, S., & Mizuno, N. (2002) · Drug Development and Industrial Pharmacy · doi:10.1081/ddc-120015362 · Cited by 34
Research works printed but not linked: 30
- Walkley, 1972, Bound water in stratum corneum measured by differential scanning calorimetry, J. Invest. Dermatol., 59, 225, 10.1111/1523-1747.ep12627251 · doi:10.1111/1523-1747.ep12627251
- Kligman, 1965, Topical pharmacology and toxicology of dimethylsulfoxide, J. Am. Med. Assoc., 193, 796, 10.1001/jama.1965.03090100042010 · doi:10.1001/jama.1965.03090100042010
- Bennett, 1984, Optimisation of bioavailability of topical steroids: non-occluded penetration enhancers under thermodynamic control, J. Pharm. Pharmacol., 37, 298, 10.1111/j.2042-7158.1985.tb05070.x · doi:10.1111/j.2042-7158.1985.tb05070.x
- Oertel, 1997, Protein conformational changes induced in human stratum corneum by organic sulphoxides: an infrared spectroscopic investigation, Biopolymer, 16, 2329, 10.1002/bip.1977.360161017 · doi:10.1002/bip.1977.360161017
- J.W. Wiechers, Absorption, distribution, metabolism, and exretion of the cutaneous penetration enhancer Azone, Ph.D. thesis, University of Groningen, 1989.
- Wiechers, 1990, Transdermal drug delivery: efficacy and potential applications of the penetration enhancer Azone, Drug Des. Deliv., 6, 87
- M.I. Afouna, T.K. Fincher, A.A.A. Zaghloul, I.K. Reddy, Effect of Azone upon the in vivo antiviral efficacy of cidofovir or acyclovir topical formulations in treatment/prevention of cutaneous HSV-1 infections and its correlation with skin target site free drug concentration in hairless mice, Int. J. Pharm. 253 (2003) 159–168. · doi:10.1016/s0378-5173(02)00705-6
- Park, 2001, Effects of adhesives and permeation enhancers on the skin permeation of captopril, Drug Dev. Ind. Pharm., 27, 975, 10.1081/DDC-100107679 · doi:10.1081/ddc-100107679
- Funke, 2002, Transdermal delivery of highly lipophilic drugs: in vitro fluxes of antiestrogens, permeation enhancers, and solvents from liquid formulations, Pharm. Res., 19, 661, 10.1023/A:1015314314796 · doi:10.1023/a:1015314314796
- Aboofazeli, 2002, Transdermal delivery of nicardipine: an approach to in vitro permeation enhancement, Drug Deliv., 9, 239, 10.1080/10717540260397855 · doi:10.1080/10717540260397855
- Berner, 1989, Ethanol: water mutually enhanced transdermal therapeutic system: II. Skin permeation of ethanol and nitroglycerin, J. Pharm. Sci., 78, 402, 10.1002/jps.2600780512 · doi:10.1002/jps.2600780512
- Friend, 1988, Transdermal delivery of levonorgestrel I. Alkanols as permeation enhancers, J. Control. Release, 7, 243, 10.1016/0168-3659(88)90057-0 · doi:10.1016/0168-3659(88)90057-0
- Pershing, 1990, Mechanism of ethanol-enhanced estradiol permeation across human skin in vivo, Pharm. Res., 7, 170, 10.1023/A:1015832903398 · doi:10.1023/a:1015832903398
- Kurihara-Bergstrom, 1990, Percutaneous absorption enhancement of an ionic molecule by ethanol–water systems in human skin, Pharm. Res., 7, 762, 10.1023/A:1015879925147 · doi:10.1023/a:1015879925147
- Thomas, 2003, Transdermal delivery of zidovudine: effect of vehicles on permeation across rat skin and their mechanism of action, Pharm. Sci., 18, 71
- Morimoto, 2002, In vitro skin permeation of morphine hydrochloride during the finite application of penetration-enhancing system containing water, ethanol and l-menthol, Biol. Pharm. Bull., 25, 134, 10.1248/bpb.25.134 · doi:10.1248/bpb.25.134
- Watkinson, 1998, Skin penetration of a series of nonoxynol homologues, vol. 5b, 54
- Sarpotdar, 1986, Percutaneous absorption enhancement by non-ionic surfactants, Drug Dev. Ind. Pharm., 12, 1625, 10.3109/03639048609042599 · doi:10.3109/03639048609042599
- Sarpotdar, 1986, Evaluation of penetration enhancement of lidocaine by non-ionic surfactants through hairless mouse skin in vitro, J. Pharm. Sci., 75, 176, 10.1002/jps.2600750216 · doi:10.1002/jps.2600750216
- Yu, 1988, Percutaneous absorption of nicardipine and ketorolac in rhesus monkeys, Pharm. Res., 5, 457, 10.1023/A:1015900804327 · doi:10.1023/a:1015900804327
- Gloor, 2001, Clinical effect of salicylic acid and high dose urea applied in standardized NRF formulations, Pharmazie, 56, 810
- Wong, 1989, Unsaturated cyclic ureas as new non-toxic biodegradable transdermal penetration enhancers: II. Evaluation study, Int. J. Pharm., 52, 191, 10.1016/0378-5173(89)90220-2 · doi:10.1016/0378-5173(89)90220-2
- Williams, 1989, Urea analogues in propylene glycol as penetration enhancers in human skin, Int. J. Pharm., 56, 43, 10.1016/0378-5173(89)90059-8 · doi:10.1016/0378-5173(89)90059-8
- Williams, 1989, Essential oils as novel human skin penetration enhancers, Int. J. Pharm., 57, R7, 10.1016/0378-5173(89)90310-4 · doi:10.1016/0378-5173(89)90310-4
- Okabe, 1989, Effect of limonene and related compounds on the percutaneous absorption of indomethacin, Drug Des. Deliv., 4, 313
- B.W. Barry, A.C. Williams, Human skin penetration enhancement: the synergy of propylene glycol with terpenes, Proceedings of the 16th International Symposium on Controlled Release Bioactive Material, Chicago, USA, 1989, pp. 33–34.
- Cornwell, 1994, Sesquiterpene components of volatile oils as skin penetration enhancers for the hydrophilic permeant 5-fluorouracil, J. Pharm. Pharmacol., 46, 261, 10.1111/j.2042-7158.1994.tb03791.x · DOI · Paper page
- El-Kattan, 2000, The effect of terpene enhancer lipophilicity on the percutaneous permeation of hydrocortisone formulated in HPMC gel systems, Int. J. Pharm., 198, 179, 10.1016/S0378-5173(00)00330-6 · doi:10.1016/s0378-5173(00)00330-6
- Cal, 2001, In vitro studies on penetration of terpenes from matrix-type transdermal systems through human skin, Int. J. Pharm., 224, 81, 10.1016/S0378-5173(01)00744-X · doi:10.1016/s0378-5173(01)00744-x
- Kato, 1987, Effect of egg-yolk lecithin on transdermal delivery of bunazosin hydrochloride, J. Pharm. Pharmacol., 39, 399, 10.1111/j.2042-7158.1987.tb03407.x · doi:10.1111/j.2042-7158.1987.tb03407.x
Cited by
Prausnitz, M. R., & Langer, R. (2008) · Nature Biotechnology · doi:10.1038/nbt.1504 · Cited by 3,517
Microneedles for transdermal drug delivery
Prausnitz, M. R. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.10.023 · Cited by 1,521
Edris, A. E. (2007) · Phytotherapy Research · doi:10.1002/ptr.2072 · Cited by 1,261
Microneedles: A smart approach and increasing potential for transdermal drug delivery system
Waghule, T., Singhvi, G., Dubey, S. K., Pandey, M. M., Gupta, G., Singh, M., & Dua, K. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.10.078 · Cited by 1,260
Alkilani, A., McCrudden, M. T., & Donnelly, R. (2015) · Pharmaceutics · doi:10.3390/pharmaceutics7040438 · Cited by 1,147
Metadata
- Authors
- Williams, A. C., & Barry, B. W.
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2004-03
- Volume
- 56
- Issue
- 5
- Pages
- 603-618
- ISSN
- 0169-409X (ISSN-L)
- OpenAlex
- W4240821889
- Cited by
- 1,746
- References
- 31
- FWCI
- 2.81
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.